The moonlighting activity of one enzyme from the tuberculosis bacterium makes it partially resistant to a family of broad-spectrum antibiotics, according to a paper published in the September issue of the journal Microbiology.
"Glutamate racemase, or MurI, is an enzyme that bacteria use to make the building blocks of cell walls," said Professor Valakunja Nagaraja from the Indian Institute of Science in Bangalore, India. "MurI from Mycobacterium tuberculosis also stops the enzyme DNA gyrase from working, which in turn stops DNA replication and cell division."
The researchers found that the two different functions work independently of one another - the enzyme's ability to make cell wall components does not affect its ability to inhibit DNA gyrase and vice versa.
DNA gyrase is involved in DNA replication, which happens when bacteria reproduce. A family of antibiotics called fluoroquinolones target this enzyme, killing the bacteria that cause infections such as cholera, anthrax, gonorrhoea, meningitis, E. coli and MRSA. The researchers found that when MurI binds to DNA gyrase, it takes gyrase away from substrate DNA. Because of this, antibiotics cannot bind and stop it from working, so the bacteria become resistant to treatment.
"Our findings suggest that MurI has a role in safeguarding DNA gyrase from attack by antibiotics," said Professor Nagaraja. "The moonlighting activity of MurI seems to have evolved more recently to protect and control DNA gyrase."
MurI is not alone in its moonlighting activities; other bacterial enzymes and proteins also carry out different functions. But why has this ability evolved? "Multifunctional proteins are mostly common enzymes that have acquired different roles over the long period of their existence," said Professor Nagaraja. "As long as these additional roles do not interfere with the original function of the protein, they could benefit the cell by providing a competitive advantage during evolution."
By having multifunctional enzymes, a cell has fewer proteins to build, therefore less DNA to replicate. This means they save a great deal of energy in growth and reproduction. Moonlighting proteins can also control cellular activities, such as DNA replication in the case of MurI.
"An alarming increase in the emergence of multi-drug resistant strains of M. tuberculosis has led to an active search for novel drug targets," said Professor Nagaraja. "Our results may help us to discover molecules to target MurI, to prevent bacteria from making cell walls and develop a successful treatment for a wide range of bacterial infections."
Lucy Goodchild | alfa
Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute
Snap, Digest, Respire
20.01.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Life Sciences
20.01.2017 | Physics and Astronomy
20.01.2017 | Materials Sciences